Clinical Trials Browser

Glioma × ruxolitinib × Clear all

NCT03514069 2026-02-19

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Phase 1 Active not recruiting

Glioblastoma, Glioma